Making the step from academia into industry can seem daunting and can appear to require a very different skill set.
In April, Synpromics attended the 6th annual Alliance for Regenerative Medicine Cell & Gene Therapy Investor Day in New York, a full-day conference featuring discussi
As product developers move toward 2nd generation gene and cell medicine constructs, the importance of novel gene regulation and promoter elements has emerged.
Bringing synthetic biology to transcriptional regulation could catalyse a new generation of gene therapies that are more tunable, disease-specific and easy to deliver than the products dominating the field.
Artificial Intelligence is a hot topic of conversation in pretty much every industry all the way from manufacturing to education.